COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Rush University Medical Center

S. Jain

New European Guidelines on Pulmonary Embolism: What Has Changed and …

PERT Consortium 2021

S. Konstantinides

CRT 2025 Insights: Why Thrombo-Embolism Is a Percutaneous First Trea…

CRT 2025 Insights

G. Ansel

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

Bleeding Management and Use of Anticoagulants: Panel Discussion

PERT Consortium 2021

G. Piazza, M. McDaniel, M. Huisman, D. Siegal, C. Pollack

Pulmonary Embolism During Pregnancy

Pulmonary Embolism 2016

J. Bartholomew

TCT 2022: Why Intervene on Submassive Pulmonary Embolism Patients?

TCT 2022 Conference Coverage

W. Jaber

Extended Anticoagulation for VTE

Jeffrey Weitz

Catheter-Based Interventions for Acute Pulmonary Embolism: What Are …

Mount Sinai Endovascular Fellows Course

J. Giri

Update on HI-PEITHO - A Landmark Clinical Trial in PE

PERT Consortium 2022

K. Rosenfield

Management of Acute Pulmonary Embolism: How Long Do You Treat?

NYU Langone

N. Amoroso

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary H…

Igor F. Palacios, MD Lectureship and Symposium 2024

K. Rosenfield, I. Inglessis-Azuaje

ATS 2023 Insights: Pulmonary Vascular Disease - Clinical Year in Rev…

ATS 2023 Insights

G. Heresi

Long Term Anticoagulation - How and For How Long?

Pulmonary Embolism Symposium (PERT 2017)

Triaging Acute Pulmonary Embolism for Home Treatment or Simplified P…

PERT Consortium 2021

M. Huisman

CTEPH - Chronic Thromboembolic Pulmonary Hypertension Thoughts on Di…

Mitral Foundation

R. Martin, A. Anyanwu

MERCURY-PE Trial: Does the Outpatient Treatment with Rivaroxaban Dec…

William Peacock

Medical Management of PE

NY Endovascular Summit

J. Goldfinger

PE in the Ambulatory and Hospital Settings: Scope of the Problem

PERT Consortium 2021

G. Barnes